epilepsy

Showing NaN - NaN of 64

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SLC13A5 Deficiency Natural History Study - United States Only

Recruiting
  • Citrate Transporter Deficiency
  • +9 more
    • Palo Alto, California
    • +2 more
    Nov 17, 2023

    Epilepsy Trial in Worldwide (USL261)

    Terminated
    • Epilepsy
    • Phoenix, Arizona
    • +57 more
    Jan 19, 2023

    Epilepsy Trial in United States (Diazepam Nasal Spray [Valtoco])

    Recruiting
    • Epilepsy
    • Diazepam Nasal Spray [Valtoco]
    • Gulf Breeze, Florida
    • +12 more
    Oct 25, 2022

    Epilepsy, Seizures, Cognitive Impairment, Mild Trial in Dallas (Scopolamine (5ug/kg), Placebo)

    Recruiting
    • Epilepsy
    • +4 more
    • Scopolamine (5ug/kg)
    • Placebo
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Oct 20, 2022

    Brain Metabolism Observed at 7 Tesla

    Recruiting
    • Glut1 Deficiency Syndrome 1
    • +6 more
    • Magnetic resonance imaging
    • Dallas, Texas
      UT Southwestern Medical Center
    Aug 24, 2022

    RNSĀ® System Epilepsy PAS

    Active, not recruiting
    • Epilepsy
    • RNS System
    • Birmingham, Alabama
    • +34 more
    Mar 30, 2022

    Epilepsy, GLUT1DS1, Glut1 Deficiency Syndrome 1, Autosomal Recessive Trial in Dallas (Triheptanoin)

    Active, not recruiting
    • Epilepsy
    • +6 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 1, 2022

    Epilepsy Trial in Worldwide (Lacosamide)

    Completed
    • Epilepsy
    • Birmingham, Alabama
    • +68 more
    Dec 17, 2021

    Epilepsy Trial in Worldwide (Brivaracetam)

    Completed
    • Epilepsy
    • Phoenix, Arizona
    • +183 more
    Aug 16, 2021

    Epilepsy Trial in Worldwide (Brivaracetam)

    Completed
    • Epilepsy
    • Phoenix, Arizona
    • +99 more
    Aug 16, 2021

    GLUT1DS1, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive Trial in Dallas (Triheptanoin)

    Active, not recruiting
    • GLUT1DS1
    • +6 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jul 30, 2021

    Status Epilepticus, Convulsive Status EPILEPTICUS, Non-Convulsive Status Epilepticus Trial in United States (Ganaxolone,

    Recruiting
    • Status Epilepticus
    • +3 more
    • Birmingham, Alabama
    • +61 more
    Jun 7, 2021

    Epilepsy Trial in Australia, Jamaica, United States (Staccato Alprazolam, Placebos)

    Completed
    • Epilepsy
    • Staccato Alprazolam
    • Placebos
    • Birmingham, Alabama
    • +66 more
    Feb 2, 2021

    Epilepsy Trial in Worldwide (pregabalin)

    Completed
    • Epilepsy
    • Phoenix, Arizona
    • +43 more
    Jan 22, 2021

    Epilepsy Trial in Worldwide (Lacosamide)

    Completed
    • Epilepsy
    • Birmingham, Alabama
    • +22 more
    Nov 26, 2020

    Epilepsy Trial in United States (ezogabine/retigabine)

    Terminated
    • Epilepsy
    • Los Angeles, California
    • +3 more
    Nov 20, 2020

    Epilepsy Trial in United States (retigabine/ezogabine)

    Terminated
    • Epilepsy
    • Los Angeles, California
    • +3 more
    Oct 8, 2020

    Childhood Absence Epilepsy, Petit Mal Epilepsy, Epilepsy Trial in United States (Ethosuximide, Lamotrigine, Valproic acid)

    Completed
    • Childhood Absence Epilepsy
    • +3 more
    • Birmingham, Alabama
    • +30 more
    Sep 18, 2020

    Epilepsy Trial in Germany, United States (VX-765 Part A, Placebo, VX-765 Part B)

    Terminated
    • Epilepsy
    • VX-765 Part A
    • +2 more
    • Northport, Alabama
    • +23 more
    Sep 22, 2020

    Epilepsy Trial in Worldwide (Ezogabine: USAN Retigabine (International Nonproprietary Name))

    Completed
    • Epilepsy
    • Ezogabine: USAN Retigabine (International Nonproprietary Name)
    • Birmingham, Alabama
    • +50 more
    Jul 14, 2020

    Pharmacokinetics of Anti-epileptic Drugs in Obese Children

    Completed
    • Epilepsy
    • Obese
    • Anti-epileptics
    • Aurora, Colorado
    • +9 more
    Jun 2, 2020

    Epilepsy Trial in Tampa, Austin, Dallas (SPEAC System)

    Unknown status
    • Epilepsy
    • SPEAC System
    • Tampa, Florida
    • +2 more
    Dec 18, 2019

    Epilepsy Trial in United States (USL261)

    Terminated
    • Epilepsy
    • Tucson, Arizona
    • +15 more
    Oct 8, 2019